BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1,012 Cr | ₹1,973 Cr | ₹-383 Cr | ₹619 Cr | ₹-280 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BIOCON ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-1,012 Cr |
| Mar2025 | ₹1,973 Cr |
| Mar2024 | ₹-383 Cr |
| Mar2023 | ₹619 Cr |
| Mar2022 | ₹-280 Cr |
How is Net Cash Inflow / Outflow of BIOCON Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,012 Cr | Negative | |
| Mar2025 | ₹1,973 Cr | Positive | |
| Mar2024 | ₹-383 Cr | Negative | |
| Mar2023 | ₹619 Cr | Positive | |
| Mar2022 | ₹-280 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹68,088.9 Cr | 0.9% | -3% | 16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 0.9% |
-3% |
16.7% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses